Renal disEAse observational CoHort Database-ROxadustat in treating Anemia in Dialysis patients

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900025765

Enrollment

Unknown

Registered

2019-09-07

Start date

2019-10-01

Completion date

Unknown

Last updated

2019-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease

Interventions

Case series:N/A

Eligibility

Sex/Gender

All

Age

18 Years to 110 Years

Inclusion criteria

Inclusion criteria: Dialysis anemia patients under Roxadustat treatment who are consent to provide clinical information.

Exclusion criteria

Exclusion criteria: Patients who are not consent to study protocol or withdraw consent during the observation.

Design outcomes

Primary

Measure	Time frame
major adverse cardiac events;	—

Countries

China

Contacts

Public ContactDaqing Hong

Sichuan Provincial People's Hospital

hongdaqing11@126.com+86 18981838230

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 24, 2026